Back to today’s briefing

Story perspectives

Experts Push to Remove Outdated Menopause Therapy Warnings

7/19/2025

46 3

Summary

Story summary

On July 17, 2025, a pivotal FDA panel convened to address menopause hormone therapy (MHT) and the contentious removal of its warning labels. With FDA Commissioner Martin Makary leading the charge, experts passionately argued that outdated warnings hinder women's access to vital treatment, urging for updated labels to enhance health outcomes and empower women.

1 of 1

Story summary

On July 17, 2025, a pivotal FDA panel convened to address menopause hormone therapy (MHT) and the contentious removal of its warning labels. With FDA Commissioner Martin Makary leading the charge, experts passionately argued that outdated warnings hinder women's access to vital treatment, urging for updated labels to enhance health outcomes and empower women.